Potentially relevant to this ER-positive/PR-negative phenotype is the fact that growth-factor-activated pathways downregulate PR expression [22-25], and that the inverse correlation between overexpression of the ERBB2 growth factor receptor and PR positivity is only seen in breast cancers arising after age 40 [26]. Here, PGR is linked to breast carcinoma.